Patents by Inventor David Osborne
David Osborne has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20140255814Abstract: A combined water and anode knock-out purge line for a fuel cell including an inlet portion having an inlet portion lower surface, an outlet portion having an outlet portion lower surface, a middle portion having a lower surface and extending between the inlet portion and the outlet portion. Each lower surface of the inlet portion and outlet portion is raised relative to the lower surface of the middle portion in a generally longitudinal direction.Type: ApplicationFiled: March 11, 2013Publication date: September 11, 2014Applicant: FORD GLOBAL TECHNOLOGIES, LLCInventors: Craig Michael Mathie, William F. Sanderson, Virgo Edwards, Kurt David Osborne
-
Publication number: 20140212776Abstract: An apparatus for delivering a primary fuel stream to a fuel cell stack is provided. The apparatus includes an ejector that is configured to receive the primary fuel stream from a fuel supply. The apparatus is further configured to receive the recirculated fuel stream from the fuel cell stack to provide a combined fluid stream for delivery to the fuel cell stack. The ejector includes an elastic conduit for varying a flow of the combined fluid stream based on a power level of the fuel cell stack.Type: ApplicationFiled: January 25, 2013Publication date: July 31, 2014Applicant: FORD GLOBAL TECHNOLOGIES, LLCInventors: Kurt David Osborne, Mark A. Pellerin, Milos Milacic
-
Publication number: 20130183714Abstract: The present invention relates to a method for culturing mammalian cells in a culture medium which is transferrin free and which contains no lipophilic or synthetic nitrogen-containing chelators. Also provided is the use of the medium and a process for providing a mammalian product by culturing cells capable of producing the product in the medium.Type: ApplicationFiled: December 20, 2012Publication date: July 18, 2013Applicant: Medimmune LimitedInventors: Matthew David Osborne, Jonathan H. Dempsey
-
Patent number: 8361797Abstract: The present invention relates to a method for culturing mammalian cells in a culture medium which is transferrin free and which contains no lipophilic or synthetic nitrogen-containing chelators. Also provided is the use of the medium and a process for providing a mammalian product by culturing cells capable of producing the product in the medium.Type: GrantFiled: July 28, 2004Date of Patent: January 29, 2013Assignee: Medimmune LimitedInventors: Matthew David Osborne, Jonathan H. Dempsey
-
Patent number: 8158291Abstract: A system for delivering a supply fluid stream to a fuel cell stack that discharges an unused fluid stream is provided. A fuel supply is adapted to provide a pressurized supply fluid stream. An expander is in fluid communication with the fuel supply and is configured to receive the pressurized supply fluid stream to reduce the pressure of the pressurized supply fluid stream and to generate mechanical energy in response to reducing the pressure of the pressurized supply fluid stream. An electric machine is operably coupled to the expander and for selectively converting the mechanical energy generated by the expander into electrical energy. A compressor/blower is capable of being driven by at least one of the mechanical energy and the electrical energy to control the flow of the unused fluid stream to the fuel cell stack for recirculating the unused fluid stream back to the fuel cell stack.Type: GrantFiled: December 3, 2007Date of Patent: April 17, 2012Assignee: Ford Motor CompanyInventors: Kurt David Osborne, Keith Andrew Oglesby
-
Publication number: 20110196040Abstract: The invention relates to pharmaceutical compositions and related methods for the topical administration of polar drugs. In a particular embodiment, the invention relates to a pharmaceutical composition comprising an active pharmaceutical agent that is a polar drug, such as potassium 2,5-dihydroxybenzenesulfonate, at least one occlusive agent, and at least one stabilizer.Type: ApplicationFiled: February 17, 2009Publication date: August 11, 2011Applicant: Action Medicines S.L.Inventors: David Osborne, Pramod P. Sarpotdar, Arturo J. Angel, Inigo Saenz De Tejada, Maria Luisa Krauel
-
Patent number: 7943260Abstract: A system and method for delivering an input fluid stream through a fuel cell stack and discharge an unused fluid stream is provided. An inlet of the fuel cell stack is adapted to receive the fluid stream. An ejector is configured to combine the supply fluid stream and the unused fluid stream to generate the input fluid stream and control the flow of the input fluid stream to the fuel cell stack. A blower is configured to control the flow of the unused fluid stream to the ejector. A bypass valve is configured to control the flow of the unused fluid stream to the blower and to the ejector.Type: GrantFiled: July 31, 2007Date of Patent: May 17, 2011Assignee: Ford Motor CompanyInventors: Fred G. Brighton, Kurt David Osborne, Milos Milacic
-
Publication number: 20100304426Abstract: Embodiments relating to methods, processes and systems for measuring progesterone are provided. In particular, methods permit measurement and quantification of synthetic and/or endogenous progesterone from a progesterone-containing blood fluid sample by measuring a progesterone carbon isotope ratio by mass spectrometry and calculating the fraction of synthetic progesterone in the sample from the isotope ratio. Also provided are methods of evaluating bioequivalence of a synthetic progesterone composition using any of the methods provided herein. In an embodiment, methods of precise measurements of plasma levels are described for detection of progesterone analytes such as total progesterone, endogenous animal progesterone, and synthetic progesterone. Correcting for fluctuations in endogenous progesterone levels following application of synthetic progesterone allows a significant reduction in the number of test subjects required to evaluate bioequivalence of a synthetic progesterone composition.Type: ApplicationFiled: May 26, 2010Publication date: December 2, 2010Inventors: David OSBORNE, Paul WINKLER
-
Publication number: 20100304099Abstract: Adherent fabric articles and uses therefor are disclosed and described. In one aspect, an adherent fabric article may include a fabric layer bonded to a cling layer. In use, the fabric layer can be used to clean, polish, or treat a surface of a device, such as a scratch sensitive surface. Once cleaning, polishing, or treating is complete, the adherent fabric article can be stored on the device by adhering it to a smooth surface on the device using the cling layer. Moreover, in this position, the article may be used to protect the surface of the device to which the article is adhered. Further, the fabric portion of the article may be imaged to allow the article to be decorative in nature when adorning a device, or to provide messaging or advertisement.Type: ApplicationFiled: May 28, 2010Publication date: December 2, 2010Inventors: David Osborne, Darren Jones
-
Patent number: 7826943Abstract: A method for diagnosing faults in a particular device within a fleet of devices is provided. The method comprises receiving performance data related to one or more parameters associated with a fleet of devices and processing the performance data to detect one or more trend shifts in the one or more parameters. The method then comprises detrending the one or more parameters to derive noise-adjusted performance data related to a particular parameter associated with a particular device. The method further comprises generating a fleet-based diagnostic model based on trend patterns and data characteristics associated with the fleet of devices. The fleet-based diagnostic model comprises one or more fuzzy rules defining one or more expected trend shift data ranges for the one or more parameters associated with the fleet of devices.Type: GrantFiled: April 2, 2007Date of Patent: November 2, 2010Assignee: General Electric CompanyInventors: Lijie Yu, Daniel Joseph Cleary, Mark David Osborne
-
Publication number: 20100183936Abstract: A modular fuel cell power system includes a coolant source, a reactant source and a plurality of fuel cell modules. Each of the fuel cell modules includes a fuel cell stack and a fluid distribution plant in fluid communication with the reactant source, coolant source and fuel cell stack. The fluid distribution plant controls the flow of reactant between the reactant source and fuel cell stack. The fuel cell stacks are configured to be selectively electrically connected.Type: ApplicationFiled: January 16, 2009Publication date: July 22, 2010Applicant: FORD MOTOR COMPANYInventors: Kurt David Osborne, Donald Paul Alessi
-
Publication number: 20100018119Abstract: A monitor for monitoring the concentration of oxygen in a fuel or in an ullage over a fuel comprises (i) a sensing element comprising a luminescent substance comprising a luminophore and a support in which the luminophore is covalently bound to the support, (ii) a light source arranged to irradiate the sensing element with light, and (iii) a photosensor arranged to detect light emitted from the luminescent substance. The luminescent substance may be, for example, a platinum porphyrin covalently bound to silica.Type: ApplicationFiled: July 14, 2009Publication date: January 28, 2010Applicant: AIRBUS OPERATIONS LTDInventors: Joseph K-W LAM, David OSBORNE, Norman Mark RATCLIFFE
-
Publication number: 20090208789Abstract: A system for delivering an input fuel stream to a fuel cell stack to generate electrical current and to discharge an unused fuel stream is provided. A supply produces a supply fuel stream. An ejector combines a purged fuel stream and the supply fuel stream and controls the flow of the input fuel stream to the fuel cell stack. A purging arrangement receives the unused fuel stream which includes impurities and purges the impurities from the unused fuel stream to generate the purged fuel stream. A bypass valve is capable of delivering the purged fuel stream to the ejector. A blower is capable of delivering the purged fuel stream to the ejector. A controller controls one of the bypass valve and the blower for delivering the purged fuel stream to the ejector based on the amount of electrical current generated by the fuel cell stack.Type: ApplicationFiled: February 19, 2008Publication date: August 20, 2009Applicant: Ford Motor CompanyInventors: Suriyaprakash Ayyangar Janarthanam, Victor Dobrin, Scott Aaron Black, Milos Milacic, Kurt David Osborne
-
Publication number: 20090142644Abstract: A system for delivering a supply fluid stream to a fuel cell stack that discharges an unused fluid stream is provided. A fuel supply is adapted to provide a pressurized supply fluid stream. An expander is in fluid communication with the fuel supply and is configured to receive the pressurized supply fluid stream to reduce the pressure of the pressurized supply fluid stream and to generate mechanical energy in response to reducing the pressure of the pressurized supply fluid stream. An electric machine is operably coupled to the expander and for selectively converting the mechanical energy generated by the expander into electrical energy. A compressor/blower is capable of being driven by at least one of the mechanical energy and the electrical energy to control the flow of the unused fluid stream to the fuel cell stack for recirculating the unused fluid stream back to the fuel cell stack.Type: ApplicationFiled: December 3, 2007Publication date: June 4, 2009Applicant: FORD MOTOR COMPANYInventors: Kurt David Osborne, Keith Andrew Oglesby
-
Publication number: 20090035618Abstract: A system and method for delivering an input fluid stream through a fuel cell stack and discharge an unused fluid stream is provided. An inlet of the fuel cell stack is adapted to receive the fluid stream. An ejector is configured to combine the supply fluid stream and the unused fluid stream to generate the input fluid stream and control the flow of the input fluid stream to the fuel cell stack. A blower is configured to control the flow of the unused fluid stream to the ejector. A bypass valve is configured to control the flow of the unused fluid stream to the blower and to the ejector.Type: ApplicationFiled: July 31, 2007Publication date: February 5, 2009Applicant: FORD MOTOR COMPANYInventors: Fred G. Brighton, Kurt David Osborne, Milos Milacic
-
Publication number: 20070258919Abstract: Increased compliance in the use of topical sunscreens is obtained by combining a topical sunscreen agent in a formulation containing an antibacterial medication such as azelaic acid or an antibiotic.Type: ApplicationFiled: June 27, 2007Publication date: November 8, 2007Inventors: Arturo Angel, David Osborne, Gordon Dow
-
Publication number: 20070207192Abstract: The present invention is directed to a mucoadhesive delivery system for the local or systemic administration of a pharmaceutical agent. The delivery system of the invention effectively and facilely enables transport of the pharmaceutical agent through mucosal membranes and into the vasculattire of the mucosa. The delivery system includes an at least partially water soluble bioadhesive layer and an at least partially water soluble backing layer. Incorporated within either or both of these layers are the pharmaceutical agent and a mucosal penetration enhancing agent. The mucosal penetration enhancing agent displays localized tissue irritation properties. The mucoadhesive delivery system may be in the form of a gel, film, disc or patch. It may be applied to any mucosal membrane of a patient including but not limited to those of the buccal and nasal cavities, throat, eye, vagina, alimentary tract and peritoneum.Type: ApplicationFiled: December 22, 2006Publication date: September 6, 2007Applicant: QLT USA, Inc.Inventors: Richard Holl, David Osborne
-
Publication number: 20070122435Abstract: The present invention relates to a method of treating acne by topically applying a dermatological composition comprising dapsone. In addition to inflammatory lesions, the composition also treats non-inflammatory acne. The composition is formulated to include dapsone in a both a dissolved and microparticulate state.Type: ApplicationFiled: December 12, 2006Publication date: May 31, 2007Inventor: David Osborne
-
Publication number: 20060204526Abstract: The present invention relates to a topical, emulsive composition containing Dapsone or its derivative. The inventive composition incorporates emollients and Dapsone or its derivative in a stable emulsion. The stability is achieved through the use of a combination of certain surfactant mixtures and an enhancer providing solubility of the Dapsone.Type: ApplicationFiled: February 13, 2006Publication date: September 14, 2006Inventors: Robert Lathrop, David Osborne
-
Patent number: D618618Type: GrantFiled: March 12, 2009Date of Patent: June 29, 2010Inventors: Shawn Lee, Marcus Smith, Jeremy David Osborne Ranger